Anaphylactic shock after vaccination ‘extremely rare’

 

A sudden, serious allergic reaction—known anaphylaxis or anaphylactic shock— following vaccination, is ‘extremely rare,’ concludes research published online in the Archives of Disease in Childhood

 

London, UK (January 23, 2012) – A sudden, serious allergic reaction — known anaphylaxis or anaphylactic shock — following vaccination, is "extremely rare," concludes research published online in the Archives of Disease in Childhood. Anaphylaxis can be fatal and can be triggered by several factors, including specific foods, airborne allergens, stings and bites, and drugs/vaccines.

 

But because anaphylaxis is rare, it is usually very difficult to pick this up as a potential side effect of a new treatment during clinical trials. Manufacturers have to rely on data collected after the product has come to market.

 

The authors base their findings on children under the age of 16 in the UK and Ireland, who were suspected of having experienced anaphylaxis after being vaccinated between 2008 and 2009.

 

All the cases came from specialists, who were asked to report on any child they treated with suspected or actual anaphylaxis following a vaccination during this period to the British Paediatric Surveillance Unit.

 

During this time, 15 cases were reported following vaccination with the single measles jab; the HPV jab which is used to protect against cervical cancer; two types of vaccine for meningitis; a hepatitis A vaccine; typhoid vaccine; and a school leaver’s booster jab (probably tetanus/polio).

 

Only seven of these cases were confirmed as anaphylaxis. Six children required an injection of adrenaline and intravenous fluids. All made a full recovery; one child recovered without treatment.

 

Three of these children already carried injectable adrenaline, which is used to treat severe allergic reactions.

 

Two of the cases were associated with the single component measles vaccine. As more than 16,000 doses were imported over the study period, this gives an incidence of 12 cases of anaphylaxis for every 100,000 doses, say the authors.

 

Three of the cases were sassociated with the HPV vaccine. More than two million doses of this vaccine were administered during the study period, giving an incidence of 1.4 cases per million doses.

 

None of the cases were associated with the normal pre-school or infant immunisation schedule, including the triple MMR jab.

 

And around 5.5 million children would have received routine vaccinations during this period without any reported cases of anaphylaxis, say the authors.

 

"This is extremely reassuring data for the general public and healthcare workers alike," they conclude. "Despite its limitations, the small numbers of cases reported are likely to be a true estimate of anaphylaxis [following immunisation] rates."

 

 


BMJ-British Medical Journal, 23.01.2012 (tB).

MEDICAL NEWS

Fitness watches generate useful information, but increase patient anxiety
A new device provides added protection against COVID-19 during endoscopic…
81 million Americans lacking space or bathrooms to follow COVID…
Front-line physicians stressed and anxious at work and home
EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19…

SCHMERZ PAINCARE

Morbus Fabry mittels Datenanalysen aus dem PraxisRegister Schmerz aufspüren
Neandertaler besaßen niedrigere Schmerzschwelle
Deutscher Schmerz- und Palliativtag 2020 – ONLINE
Deutsche Gesellschaft für Schmerzmedizin fordert Anerkennung von Nicht-Psychologen in der…
DBfK: Besondere Rolle für Pflegeexpert/innen Schmerz – nicht nur in…

DIABETES

“Körperstolz”: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen
Fastenmonat Ramadan: Alte und neue Herausforderung für chronisch Erkrankte während…
Sanofi setzt sich für die Bedürfnisse von Menschen mit Diabetes…

ERNÄHRUNG

Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Fast Food, Bio-Lebensmittel, Energydrinks: neue Daten zum Ernährungsverhalten in Deutschland
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf

ONKOLOGIE

Darolutamid bei Prostatakarzinom: Hinweis auf beträchtlichen Zusatznutzen
Multiples Myelom: Wissenschaftler überprüfen den Stellenwert der Blutstammzelltransplantation
Neues zur onkologischen Supportiv- und Misteltherapie und aktuelle Kongress-Highlights zum…
Finanzierung der ambulanten Krebsberatung weiterhin nicht gesichert
Lungenkrebsscreening mittels Low-Dose-CT

MULTIPLE SKLEROSE

Geschützt: Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Bristol Myers Squibb erhält Zulassung der Europäischen Kommission für Ozanimod…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen

PARKINSON

Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Putzfimmel im Gehirn
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…